MRS. LEAH BJORNSKOV WESSENBERG FNP
Prescription History 1023200821
Nurse Practitioner - Family in Portland, OR
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. LEAH BJORNSKOV WESSENBERG FNP, an active Family specialist practicing in Portland, OR. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 25 documented patient claims. Among these therapy options, the most frequently utilized medication is Palynziq, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OR PrescribersVs. OR Avg |
|---|---|---|---|
| PalynziqPegvaliase-Pqpz | 13 | $7,625.72 | – No State Data |
About Palynziq: This medication is used by people with a certain inherited condition (phenylketonuria) to reduce high levels of a certain substance (phenylalanine) that builds up in the blood. Show more ▾ Having high levels of phenylalanine in the blood may cause brain damage, heart problems, an abnormally small head size, and behavioral problems. Pegvaliase works by breaking down phenylalanine in the blood. Along with using this medication, you should follow a special diet to control your blood phenylalanine levels. Ask your doctor for details. Pegylated recombinant Anabaena variabilis-derived phenylalanine ammonia lyase for the treatment of phenylketonuria. In 2024, this provider wrote 13 Medicare prescriptions for Palynziq. Medicare paid an average of $7,625.72 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $7,625.72 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| KuvanSapropterin Dihydrochloride | 12 | $19,166.60 | – No State Data |
About Kuvan: This medication is used along with diet changes for long-term treatment of a certain inherited disorder (phenylketonuria-PKU). Show more ▾ It helps remove a certain chemical (phenylalanine) from the body. Too much phenylalanine in the body can cause brain damage. Co-factor required for catalytic activity of nitric oxide synthases. In 2024, this provider wrote 12 Medicare prescriptions for Kuvan. Medicare paid an average of $19,166.60 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $19,166.60 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MRS. LEAH BJORNSKOV WESSENBERG FNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Portland, OR practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OR prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
